Why Chemed Stock Is Plummeting Today
(NYSE: CHE) -- home to hospice care provider Vitas Healthcare and Roto-Rooter -- saw its shares decline 9% as of 1 p.m. ET on Wednesday, according to data provided by S&P Global Market Intelligence.
Chemed reported second-quarter earnings that fell short of analysts' expectations, causing its share price to tumble.
While Chemed grew sales by 4% in Q2, adjusted earnings per share (EPS) declined by a staggering 22%. Meanwhile, management cut 2025 EPS guidance from $25.20 to $22.15, implying a 4% decline from last year's earnings.
Source Fool.com
Chemed Corp. Stock
€388.00
-1.020%
With 9 Buy predictions and not the single Sell prediction the community is currently very high on Chemed Corp..
With a target price of 515 € there is a positive potential of 32.73% for Chemed Corp. compared to the current price of 388.0 €.
